For instance, Yuan et al. (2020) showed that HOTAIR-miR-519a-3p/ribonucleoside diphosphate reductase subunit M1 (RRM1) signaling has been implicated in conferring resistance to human glioblastoma cells, A172 and LN229 against temozolomide. Here, RRM1 is linked to glioblastoma.